• InterView
• From domestic sales to the global brand general
• by Dec 22, 2022 05:53am

• InterView
• The issue of SE of JAK inhibitors should be given authority
• by Kim, Jin-Gu Dec 2, 2022 06:08am

• InterView
• The key to treating stroke tx is preventing the recurrence
• by Kim, Jin-Gu Nov 23, 2022 06:04am

• InterView
• “Korea is fully capable of developing new microbiome drugs"
• by Nho, Byung Chul Nov 18, 2022 06:04am

• InterView
• “Amgen addresses all unmet needs regardless of indication”
• by Eo, Yun-Ho Nov 17, 2022 05:54am

• InterView
• “BMS makes the next leap with its solid pipeline”
• by Eo, Yun-Ho Oct 31, 2022 06:06am

• InterView
• "Lilly rises in anticancer and autoimmune diseases"
• by Eo, Yun-Ho Oct 27, 2022 05:52am

• InterView
• “AstraZeneca’s sincerity in oncology drives cont. growth"
• by Eo, Yun-Ho Oct 17, 2022 06:03am

• InterView
• “Sanofi’s flu vaccine is different...has 100-year legacy"
• by Oct 6, 2022 06:05am

• InterView
• “Will rise independently as Organon in the industry”
• by Eo, Yun-Ho Sep 8, 2022 05:59am